Bank of Montreal’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,226
| Closed | -$46K | – | 5515 |
|
|
2021
Q1 | $46K | Sell |
1,226
-6,635
| -84% | -$165K | ﹤0.01% | 3746 |
|
|
2020
Q4 | $139K | Buy |
7,861
+6,623
| +535% | +$83K | ﹤0.01% | 3413 |
|
|
2020
Q3 | $6K | Sell |
1,238
-965
| -44% | -$4.9K | ﹤0.01% | 4391 |
|
|
2020
Q2 | $14K | Buy |
+2,203
| New | +$9.07K | ﹤0.01% | 4027 |
|
|
2020
Q1 | – | Sell |
-4,238
| Closed | -$19K | – | 5003 |
|
|
2019
Q4 | $19K | Buy |
4,238
+1,215
| +40% | +$4.81K | ﹤0.01% | 4356 |
|
|
2019
Q3 | $12K | Buy |
3,023
+165
| +6% | +$905 | ﹤0.01% | 4366 |
|
|
2019
Q2 | $17K | Buy |
+2,858
| New | +$27.3K | ﹤0.01% | 4280 |
|
|
2019
Q1 | – | Sell |
-1,248
| Closed | -$11K | – | 4953 |
|
|
2018
Q4 | $11K | Buy |
1,248
+1,011
| +427% | +$12K | ﹤0.01% | 3869 |
|
|
2018
Q3 | $3K | Sell |
237
-1,288
| -84% | -$19.2K | ﹤0.01% | 4290 |
|
|
2018
Q2 | $24K | Buy |
1,525
+351
| +30% | +$6.13K | ﹤0.01% | 3686 |
|
|
2018
Q1 | $20K | Buy |
1,174
+769
| +190% | +$15K | ﹤0.01% | 3565 |
|
|
2017
Q4 | $8K | Buy |
405
+157
| +63% | +$5.05K | ﹤0.01% | 3858 |
|
|
2017
Q3 | $10K | Buy |
248
+4
| +2% | +$126 | ﹤0.01% | 3713 |
|
|
2017
Q2 | $7K | Sell |
244
-24,756
| -99% | -$773K | ﹤0.01% | 3813 |
|
|
2017
Q1 | $904K | Sell |
25,000
-176
| -0.7% | -$7.76K | ﹤0.01% | 1895 |
|
|
2016
Q4 | $1.45M | Buy |
25,176
+75
| +0.3% | +$3.94K | ﹤0.01% | 1728 |
|
|
2016
Q3 | $1.32M | Hold |
25,101
| – | – | ﹤0.01% | 1696 |
|
|
2016
Q2 | $1.04M | Buy |
25,101
+25,083
| +139,350% | +$1.09M | ﹤0.01% | 1817 |
|
|
2016
Q1 | $1K | Sell |
18
-3,397
| -99% | -$117K | ﹤0.01% | 4122 |
|
|
2015
Q4 | $142K | Buy |
3,415
+3,403
| +28,358% | +$114K | ﹤0.01% | 2607 |
|
|
2015
Q3 | $0 | Sell |
12
-341,198
| -100% | -$7.33M | ﹤0.01% | 4231 |
|
|
2015
Q2 | $8.48M | Buy |
+341,210
| New | +$7.6M | 0.01% | 884 |
|
|
2014
Q3 | – | Sell |
-1,170
| Closed | -$18K | – | 4567 |
|
|
2014
Q2 | $18K | Buy |
1,170
+170
| +17% | +$2.44K | ﹤0.01% | 3645 |
|
|
2014
Q1 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 3489 |
|
|
2013
Q4 | $17K | Buy |
+1,000
| New | +$12.4K | ﹤0.01% | 3278 |
|
Bank of Montreal's FPRX Position: Q2 2021 in Review
Bank of Montreal sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 1,226 shares — an estimated $46K sold.
Bank of Montreal first reported a position in FPRX in Q4 2013 and held it in 25 quarters. The position peaked at $8.48M in Q2 2015. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Bank of Montreal reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Bank of Montreal sold 1,226 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $46K.
- Bank of Montreal first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 25 quarters.
- Bank of Montreal's Five Prime Therapeutics, Inc. position peaked at $8.48M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.